159 related articles for article (PubMed ID: 17206396)
21. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
Ceyla I; Tuba TK; Adisen E; Banu O; Isil F; Ali GM; Turgut I; Banu B
J Neurol Sci; 2012 Apr; 315(1-2):120-2. PubMed ID: 22177089
[TBL] [Abstract][Full Text] [Related]
22. Plasma thrombomodulin levels in patients with Behçet's disease.
Düzgün N; Ayaşlioğlu E; Tutkak H; Sahin M; Aydintuğ O; Olmez U
Rheumatol Int; 2003 May; 23(3):130-3. PubMed ID: 12739044
[TBL] [Abstract][Full Text] [Related]
23. Soluble form of selectins in blood of patients with acute myocardial infarction and coronary intervention.
Sakurai S; Inoue A; Koh CS; Owa M; Yanagisawa N
Vasc Med; 1997; 2(3):163-8. PubMed ID: 9546964
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Colchicine on Mean Platelet Volume in Behcet's Disease.
Ataş H; Cemil BC; Canpolat F; Gönül M
Ann Clin Lab Sci; 2015; 45(5):545-9. PubMed ID: 26586706
[TBL] [Abstract][Full Text] [Related]
25. Serum concentrations of soluble (s)L- and (s)P-selectins in women with ovarian cancer.
Majchrzak-Baczmańska DB; Głowacka E; Wilczyński M; Malinowski A
Prz Menopauzalny; 2018 Mar; 17(1):11-17. PubMed ID: 29725279
[TBL] [Abstract][Full Text] [Related]
26. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity.
Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550
[TBL] [Abstract][Full Text] [Related]
27. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
[TBL] [Abstract][Full Text] [Related]
28. Elevation of serum soluble E-selectin and VCAM-1 in severe asthma.
Hamzaoui A; Ammar J; El Mekki F; Borgi O; Ghrairi H; Ben Brahim M; Hamzaoui K
Mediators Inflamm; 2001 Dec; 10(6):339-42. PubMed ID: 11817675
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of Angiopoietin-1 in Behcet's disease patients with vascular involvement.
Bassyouni IH; Sharaf M; Wali IE; Mansour HM
Heart Vessels; 2016 Jun; 31(6):918-24. PubMed ID: 25964071
[TBL] [Abstract][Full Text] [Related]
30. Levels of soluble Fas/APO-1 in patients with Behçet's disease.
Hamzaoui K; Hamzaoui A; Zakraoui L; Chabbou A
Mediators Inflamm; 1998; 7(2):111-4. PubMed ID: 9836498
[TBL] [Abstract][Full Text] [Related]
31. Increased serum ferritin levels in active Behçet's disease.
Odabas AR; Karakuzu A; Cetinkaya R; Selcuk Y; Keles S; Bilen H
Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217
[TBL] [Abstract][Full Text] [Related]
32. Alterations in the serum levels of soluble L, P and E-selectin 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study.
Yaraee R; Ghazanfari T; Faghihzadeh S; Mostafaie A; Soroush MR; Inai K; Foroutan A; Shams J; Naghizadeh MM; Hassan ZM
Int Immunopharmacol; 2009 Dec; 9(13-14):1477-81. PubMed ID: 19733695
[TBL] [Abstract][Full Text] [Related]
33. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
34. Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.
Yuksel M; Yildiz A; Oylumlu M; Turkcu FM; Bilik MZ; Ekinci A; Elbey B; Tekbas E; Alan S
Clin Rheumatol; 2016 Mar; 35(3):701-8. PubMed ID: 25744156
[TBL] [Abstract][Full Text] [Related]
35. Serum GDF-15 level in Behçet's disease: relationships between disease activity and clinical parameters.
Sarıyıldız MA; Yazmalar L; Batmaz İ; Alpaycı M; Burkan YK; Sula B; Kaplan İ; Yıldız M; Akar ZA; Bozkurt M
Int J Dermatol; 2016 Nov; 55(11):1289-1294. PubMed ID: 27206990
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
[TBL] [Abstract][Full Text] [Related]
37. Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism.
Wenisch C; Myskiw D; Gessl A; Graninger W
J Clin Endocrinol Metab; 1995 Jul; 80(7):2122-6. PubMed ID: 7541802
[TBL] [Abstract][Full Text] [Related]
38. Serum E-selectin and beta 2-microglobulin levels in Behçet's disease.
Karakuzu A; Aktaş A; Akçay F
J Int Med Res; 2002; 30(1):85-8. PubMed ID: 11921504
[TBL] [Abstract][Full Text] [Related]
39. Decreased sL-selectin serum levels in sleep apnea syndrome patients with cardiovascular diseases.
Kosacka M; Porębska I; Jankowska R
Adv Clin Exp Med; 2017; 26(3):449-453. PubMed ID: 28791819
[TBL] [Abstract][Full Text] [Related]
40. Lower CYP2C9 activity in Turkish patients with Behçet's disease compared to healthy subjects: a down-regulation due to inflammation?
Goktaş MT; Hatta F; Karaca O; Kalkisim S; Kilic L; Akdogan A; Babaoglu MO; Bozkurt A; Helldén A; Bertilsson L; Yasar U
Eur J Clin Pharmacol; 2015 Oct; 71(10):1223-8. PubMed ID: 26233334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
